Aloul, K. M., Nielsen, J. E., Defensor, E. B., Lin, J. S., Fortkort, J. A., Shamloo, M., . . . Barron, A. E. (2022). Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Frontiers in immunology, 13, 880961. https://doi.org/10.3389/fimmu.2022.880961
Chicago-Zitierstil (17. Ausg.)Aloul, Karim M., Josefine Eilsø Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Jeffrey D. Cirillo, Adrian F. Gombart, und Annelise E. Barron. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology 13 (2022): 880961. https://doi.org/10.3389/fimmu.2022.880961.
MLA-Zitierstil (9. Ausg.)Aloul, Karim M., et al. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology, vol. 13, 2022, p. 880961, https://doi.org/10.3389/fimmu.2022.880961.